ARALEN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aralen Hydrochloride, and what generic alternatives are available?
Aralen Hydrochloride is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in ARALEN HYDROCHLORIDE is chloroquine hydrochloride. There are twenty drug master file entries for this compound. Additional details are available on the chloroquine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARALEN HYDROCHLORIDE?
- What are the global sales for ARALEN HYDROCHLORIDE?
- What is Average Wholesale Price for ARALEN HYDROCHLORIDE?
Summary for ARALEN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Clinical Trials: | 16 |
| Patent Applications: | 12 |
| DailyMed Link: | ARALEN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for ARALEN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Liverpool School of Tropical Medicine | Phase 4 |
| Translational Genomics Research Institute | Phase 1 |
| HonorHealth Research Institute | Phase 1 |
US Patents and Regulatory Information for ARALEN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | ARALEN HYDROCHLORIDE | chloroquine hydrochloride | INJECTABLE;INJECTION | 006002-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
